Neutralizing antibodies for the treatment of COVID-19.

Jiang, Shibo; Zhang, Xiujuan; Yang, Yang; Hotez, Peter J; Du, Lanying

Jiang, Shibo; Zhang, Xiujuan; Yang, Yang; Hotez, Peter J; Du, Lanying.

Jiang S; Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA.
Zhang X; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, China.
Yang Y; Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA.
Hotez PJ; Howard Hughes Medical Institute, Yale University, New Haven, CT, USA.
Du L; Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.

Nat Biomed Eng ; 4(12): 1134-1139, 2020 12.

Article in English | MEDLINE | ID: covidwho-967286

Subject(s)

Antibodies, Neutralizing/immunology; Antibodies, Neutralizing/therapeutic use; COVID-19 Drug Treatment; COVID-19/immunology; COVID-19/virology; Humans; Pandemics/prevention & control; SARS-CoV-2/immunology; Serum/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Nat Biomed Eng Year: 2020 Document Type: Article Affiliation country: S41551-020-00660-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google